Dr. Agarwal's Eye Hospital , a leading eye care provider, has announced robust financial results for the first quarter of the fiscal year, showcasing significant growth in both revenue and profitability.

Financial Highlights

The company reported a substantial increase in its net profit for Q1, rising to ₹17.26 crore from ₹14.11 crore in the same period last year, marking an impressive 22.32% year-over-year growth. This strong performance was underpinned by a notable increase in revenue, which climbed to ₹116.92 crore, up from ₹100.02 crore in the corresponding quarter of the previous year.

Detailed Financial Performance

A closer look at the financial results reveals:

Operational Performance

The company's EBITDA (Earnings Before Interest, Tax, Depreciation, and Amortization) for Q1 FY2026 stood at ₹37.93 crore, indicating strong operational efficiency and profitability.

Management Commentary

Dr. Amar Agarwal, Chairman and Managing Director of Dr. Agarwal's Eye Hospital Limited, commented on the results, stating, "We are pleased to report a strong start to the fiscal year with significant growth in both our top and bottom lines. Our focus on providing high-quality eye care services continues to drive our performance, and we remain committed to expanding our reach and enhancing patient care."

Board Meeting and Auditor's Review

The unaudited financial results for the quarter ended June 30, 2025, were reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on August 12, 2025. The results have also been subjected to a limited review by the company's statutory auditors, Deloitte Haskins & Sells.

Future Outlook

While specific forward-looking statements were not provided, the company's strong Q1 performance suggests a positive trajectory for the remainder of the fiscal year. Dr. Agarwal's Eye Hospital continues to focus on its core business of eye care-related sales and services, operating in a single segment.

As the company maintains its growth momentum, investors and stakeholders will be keenly watching for sustained performance in the coming quarters.

Dr Agarwals Eye Hospital , a prominent player in the eye care sector, has announced its fourth-quarter results for the fiscal year, showcasing robust growth across key financial metrics. The company has also declared a dividend, rewarding its shareholders.

Revenue Growth

The company reported a significant increase in its Q4 revenue, which rose to ₹1000.00 million from ₹810.00 million in the same quarter of the previous year. This represents a year-over-year growth of approximately 23.46%, indicating strong business performance and market demand for the company's services.

Improved Profitability

Dr Agarwals Eye Hospital demonstrated improved profitability in the fourth quarter:

• EBITDA: The company's EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) for Q4 increased to ₹317.00 million from ₹244.00 million in the previous year, marking a growth of about 29.92%.

• EBITDA Margin: The EBITDA margin improved to 31.70% from 30.12%, reflecting enhanced operational efficiency.

• Net Profit: On a standalone basis, the company's net profit for Q4 grew to ₹160.00 million from ₹128.00 million in the previous year, representing an increase of approximately 25.00%.

Financial Performance Overview

Dividend Declaration

In addition to the strong financial results, Dr Agarwals Eye Hospital has declared a dividend of ₹3.50 per share. This dividend announcement is likely to be well-received by the company's shareholders, providing them with a return on their investment.

The company's robust financial performance, marked by significant growth in revenue and profitability, along with the dividend declaration, underscores its strong market position in the eye care sector. The improved EBITDA margin also suggests that Dr Agarwals Eye Hospital has been successful in managing its operational costs while driving growth.